Coherus BioSciences Inc. (CHRS)
1.00
-0.00 (-0.50%)
At close: Mar 04, 2025, 12:56 PM
Coherus BioSciences Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -237.89M | -291.75M | -287.1M | 132.24M | 89.83M | -209.41M | -238.29M | -127.79M | -223.94M | -87.18M | -53.63M | -33.02M |
| Depreciation & Amortization | 3.79M | 3.7M | 3.45M | 2.89M | 3.26M | 3.23M | 3.4M | 3M | 1.87M | 674K | 404K | 221K |
| Stock-Based Compensation | 43.11M | 50.74M | 51.36M | 38.16M | 33.59M | 34.8M | 36.06M | 27.42M | 16.72M | 11.06M | 2.04M | 443K |
| Other Working Capital | 136.83M | -40.41M | 13.68M | 28.75M | 66.36M | 8.04M | -2.39M | -159.53M | 71.59M | 41.46M | 42.3M | 8.3M |
| Other Non-Cash Items | 52.93M | 75.45M | 143.05M | 5.99M | 15.65M | -1.75M | 3.22M | 5.35M | 4.56M | 9.23M | 12.87M | 9.47M |
| Deferred Income Tax | n/a | n/a | 9.44M | -155K | -55K | 3.56M | 453K | -1.31M | 1.68M | 13.85M | 12.32M | -7.01M |
| Change in Working Capital | -36.83M | -79.26M | 42.36M | -32.48M | -113.93M | 10.3M | -5.13M | -159.21M | 91.11M | 28.43M | 41.41M | 11.64M |
| Operating Cash Flow | -174.88M | -241.12M | -37.43M | 154.15M | 28.36M | -159.27M | -200.29M | -252.54M | -107.99M | -23.93M | 15.42M | -18.25M |
| Capital Expenditures | -286K | -2.04M | -1.29M | -7.06M | -12.9M | -789K | -4.57M | -6.51M | -6.16M | -2.85M | -373K | -1.78M |
| Acquisitions | 845K | n/a | 1.29M | 175K | 1.66M | -700K | n/a | n/a | n/a | 2.33M | n/a | n/a |
| Purchase of Investments | -19.51M | -127.38M | -182.49M | -273.85M | -20.23M | -42.87M | -74.34M | n/a | -785K | n/a | n/a | n/a |
| Sales Maturities Of Investments | 157.64M | n/a | 181.36M | 274M | 20.4M | 43.17M | 74.5M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 5.95M | -37.43M | -137.29M | -7.67M | -1.66M | 301K | 156K | -6.51M | -785K | -10K | n/a | -40K |
| Investing Cash Flow | 144.64M | -166.85M | -138.41M | -14.4M | -12.73M | -1.19M | -4.42M | -6.51M | -6.95M | -525K | -373K | -1.82M |
| Debt Repayment | n/a | 49.93M | n/a | 222.16M | 72.95M | n/a | n/a | 100M | n/a | n/a | 9.95M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -880K | n/a | n/a | -544K | n/a | n/a | -2K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -2.12M | -1.96M | 10.98M | 1.79M | 8.26M | 3.67M | 482K | 2.57M | -111K | 50.54M | 6K | 26.94M |
| Financial Cash Flow | 69.6M | 54.33M | 51.88M | 223.95M | 89.37M | 105.42M | 206.79M | 226.18M | 122.69M | 135.96M | 9.96M | 26.94M |
| Net Cash Flow | 39.36M | -353.65M | -123.96M | 363.69M | 104.72M | -54.56M | 1.96M | -33.28M | 7.83M | 110.84M | 25.01M | 6.86M |
| Free Cash Flow | -175.17M | -243.16M | -38.72M | 147.09M | 15.46M | -160.06M | -204.86M | -259.06M | -114.15M | -26.78M | 15.05M | -20.03M |